Protonstatin-1

CAS No. 521972-99-6

Protonstatin-1( —— )

Catalog No. M36384 CAS No. 521972-99-6

Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 250 In Stock
5MG 227 In Stock
10MG 330 In Stock
25MG 566 In Stock
50MG 737 In Stock
100MG 1014 In Stock
200MG 1376 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Protonstatin-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.
  • Description
    Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    IGF-1R
  • Recptor
    IGF-1R
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    521972-99-6
  • Formula Weight
    211.26
  • Molecular Formula
    C8H5NO2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC(=S)S\C1=C/C1=CC=CO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PQ401

    PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.

  • Ganitumab

    Ganitumab (AMG 479) is a highly potent monoclonal antibody targeting the type 1 insulin-like growth factor receptor (IGF1R). Recognized for binding IGF1R at low concentrations with a KD value of 0.22 nM, Ganitumab inhibits IGF1R interactions with IGF1 and IGF2 in mice, making it useful for cancer research.

  • Tyrphostin AG 538

    Tyrphostin AG 538 is a chalcone compound, an IGF-1 receptor kinase inhibitor (IC?0 : for 400 nM) that is potent, cell-permeable, reversible, and competitive.